
Walmart's DEI rollback signals a profound shift in the wake of Trump's election victoryNone
AP Trending SummaryBrief at 3:39 p.m. ESTYes, the U.S. health care system is the most expensive in the world
Iran cyberspace council votes to lift ban on WhatsApp
Islanders finish undefeated, Titans surprise KnightsDAYTONA BEACH, Fla. (AP) — Rasheed Bello had 20 points in Purdue Fort Wayne's 87-81 victory over Drexel on Monday. Bello added eight assists for the Mastodons (4-2). Corey Hadnot II went 6 of 7 from the field (3 for 4 from 3-point range) to add 15 points. Jalen Jackson had 13 points and went 6 of 13 from the field. The Dragons (4-3) were led in scoring by Cole Hargrove, who finished with 19 points, 14 rebounds and four assists. Kobe Magee added 15 points and three steals for Drexel. Shane Blakeney finished with 12 points. Jackson scored nine points in the first half and Purdue Fort Wayne went into halftime trailing 37-35. Bello scored 15 second-half points. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
MercadoLibre trades in the green for seven straight sessionsCowboys' Mike McCarthy addresses Jerry Jones' comments about potential extension amid team's 4-7 seasonAjax lost 1-3 to Italian team SS Lazio in the Johan Cruijff ArenA on Thursday in the UEFA Europa League. The Amsterdammers equalized through Bertrand Traore early into the second half, but goals from Pedro and Fisayo Dele-Bashiru gave the leaders of the Europa League the victory. It was Ajax’s third loss in their last five matches and their second in a row in the UEFA Europa League after they lost to Real Sociedad in their previous game. Despite this, they will likely still advance in the Europa League as their next match is against RFS from Latvia, who have two points in their six games. Lazio took the lead in the 12th minute. Lazio’s experienced Spanish player Pedro played a through ball to Loum Tchaouna, whose shot went in via the Ajax goalkeeper Remko Pasveer. Ajax had a chance to equalize in the 19th minute. A cross from Rensch found Brian Brobbey, but it was just about too high for the striker. Francesco Farioli’s team made the best possible start to the second half by equalizing. Steven Berghuis’ cross was headed toward goal by Kenneth Taylor. Lazio defender Luca Pellegrini cleared the ball off the line, but it went out to Bertrand Traore, who smashed the ball into the net to make it 1-1. However, the ArenA was silenced again five minutes later as the Roman team re-took the lead. A cross from Mattia Zaccagni went to the far post where Fisayo Dele-Bashiru shot toward the goal. Pasveer thought he had saved it initially, but goalline technology showed that the ball had gone over the line. Brobbey had another chance to score later on in the half after Pellegrini’s attempt to chest the ball back to the keeper was intercepted by Brobbey, but the striker’s header went wide of the goal. Pedro followed up his assist with a terrific goal in the 77th minute. Nuno Tavares came forward from his own half, dribbling past two players before passing the ball on to Tchaouna, who laid it off to the Spaniard. Ajax created chances to equalize late on in the match. They hit the crossbar twice via Traore and Anton Gaaei before Chuba Akpom missed a significant chance to score.
Elon Musk reveals SEC sent him ‘settlement demand' after Twitter buyout probeFinancial giants have made a conspicuous bullish move on Lemonade. Our analysis of options history for Lemonade LMND revealed 20 unusual trades. Delving into the details, we found 70% of traders were bullish, while 20% showed bearish tendencies. Out of all the trades we spotted, 11 were puts, with a value of $1,950,705, and 9 were calls, valued at $1,190,845. Expected Price Movements Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $15.0 to $55.0 for Lemonade during the past quarter. Insights into Volume & Open Interest Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Lemonade's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Lemonade's substantial trades, within a strike price spectrum from $15.0 to $55.0 over the preceding 30 days. Lemonade Option Volume And Open Interest Over Last 30 Days Biggest Options Spotted: Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume LMND PUT SWEEP BULLISH 11/29/24 $4.6 $3.7 $4.3 $49.00 $460.2K 5.0K 1.2K LMND PUT TRADE BULLISH 11/29/24 $4.1 $3.6 $3.8 $49.00 $440.0K 5.0K 2.7K LMND CALL TRADE BULLISH 01/15/27 $38.6 $38.5 $38.6 $15.00 $386.0K 84 275 LMND CALL SWEEP BULLISH 01/15/27 $38.7 $38.6 $38.7 $15.00 $263.1K 84 275 LMND PUT SWEEP BULLISH 11/29/24 $2.65 $2.55 $2.55 $48.00 $250.5K 91 3.6K About Lemonade Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others. Present Market Standing of Lemonade With a volume of 2,396,176, the price of LMND is up 0.08% at $50.4. RSI indicators hint that the underlying stock may be overbought. Next earnings are expected to be released in 95 days. Expert Opinions on Lemonade A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $33.4. Unusual Options Activity Detected: Smart Money on the Move Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access .* An analyst from Piper Sandler persists with their Neutral rating on Lemonade, maintaining a target price of $44. * Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Lemonade, targeting a price of $25. * An analyst from Morgan Stanley persists with their Underweight rating on Lemonade, maintaining a target price of $23. * An analyst from BMO Capital persists with their Underperform rating on Lemonade, maintaining a target price of $15. * Consistent in their evaluation, an analyst from JMP Securities keeps a Market Outperform rating on Lemonade with a target price of $60. Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lemonade options trades with real-time alerts from Benzinga Pro . © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
In the days following the killing of UnitedHealthcare CEO Brian Thompson , people online have discussed the state of American health care, particularly its high costs. In a handwritten document expressing his views, the suspected shooter, 26-year-old Luigi Mangione, claimed that the U.S. has the most expensive health care system in the world, but ranks number 42 in life expectancy, multiple media outlets reported. Some on social media repeated the claim or made posts comparing the high costs of the U.S. healthcare system to the nation’s lower life expectancy. THE QUESTION Does the U.S. have the most expensive health care system in the world? THE SOURCES World Health Organization (WHO) Global Health Expenditure data Organisation for Economic Co-operation and Development (OECD) Peterson-KFF Health System Tracker THE ANSWER Yes, the U.S. has the most expensive health care system in the world. WHAT WE FOUND A country’s health care costs are typically measured by adding up all health care spending for people, governments, organizations and businesses, and dividing that by the total number of people in the country. The figure includes spending on personal health care, such as drugs and hospital visits, as well as collective care, such as public health services and health administration. The U.S. health care system is more expensive per person than any other country’s health care system, both in raw dollar amounts and when spending is adjusted to account for the cost of living in each country. This finding is consistent across data from multiple international organizations. In 2021, the most recent year for which the World Health Organization (WHO) Global Health Expenditure database published numbers for all countries, the U.S. spent just over $12,000 on health care per person. The only other country that spent more than $10,000 was Switzerland, which spent nearly $10,900 per person. However, when adjusted for the cost of goods in each country, the spending gap is even larger. Switzerland, which still spent the second most, spent about $9,000 on health care per person in 2021. The U.S., on the other hand, spent about $12,000 per person. Credit: VERIFY Screenshot taken from the World Bank. Looking at another dataset, in 2022, the U.S. spent nearly $12,600 on health care per person, according to the Organisation for Economic Co-operation and Development (OECD) , an international organization made up of about 40 wealthy member countries. The OECD collects data on its member countries. The OECD country that spent the next most on health care per person, when adjusted for the cost of goods in that country, was still Switzerland. It spent just over $8,000 per person, according to the OECD’s data. Wealthy countries do tend to spend more money on health care per person than lower income countries, according to the Peterson-KFF Health System Tracker , a partnership between two public health non-profit organizations. But Denmark, Switzerland, Ireland, Luxembourg and Norway are all wealthier per person than the U.S. is and spend significantly less on health care per person, according to the Health System Tracker. Ireland spends less than half of what the U.S. does on health care per person. Life expectancy and health outcomes When it comes to how the U.S. ranks for life expectancy and health outcomes, it’s true that the U.S. is behind dozens of other countries, although several international organizations don’t place the U.S. exactly at number 42. A CIA World Factbook estimate for 2024 ranked the U.S. 35th in life expectancy once territories are excluded. The WHO ranked the U.S. 45th in the world, excluding territories, in life expectancy in 2021, the most recent year for which the WHO has data for all countries. WHO data from 2019 shows that the U.S. was 40th in life expectancy prior to the pandemic. The U.S. experienced a bigger drop in life expectancy than other similarly wealthy countries during the COVID-19 pandemic, according to the Health System Tracker , which is run by the nonprofits The Peterson Center on Healthcare and KFF. The Health System Tracker explains this is because the pandemic increased mortality and premature death rates in the U.S. by more than it did in most peer countries, making the U.S. fall further behind in life expectancy. Related Articles Yes, it’s safe to use Login.gov to access Social Security accounts online VERIFYING claims related to Luigi Mangione after his arrest in the UnitedHealthcare CEO killing Why we can’t VERIFY a chart showing UnitedHealthcare denies more claims than other insurers The VERIFY team works to separate fact from fiction so that you can understand what is true and false. Please consider subscribing to our daily newsletter , text alerts and our YouTube channel . You can also follow us on Snapchat , Instagram , Facebook and TikTok . Learn More » Follow Us YouTube Snapchat Instagram Facebook TikTok Want something VERIFIED? Text: 202-410-8808Chiefs are no longer relishing close wins as the stress of the postseason push begins to mountPakistani authorities launch operation to clear Imran Khan supporters from the capital
Pfizer Declares First-Quarter 2025 Dividend
In the days following the killing of UnitedHealthcare CEO Brian Thompson , people online have discussed the state of American health care, particularly its high costs. In a handwritten document expressing his views, the suspected shooter, 26-year-old Luigi Mangione, claimed that the U.S. has the most expensive health care system in the world, but ranks number 42 in life expectancy, multiple media outlets reported. Some on social media repeated the claim or made posts comparing the high costs of the U.S. healthcare system to the nation’s lower life expectancy. THE QUESTION Does the U.S. have the most expensive health care system in the world? THE SOURCES World Health Organization (WHO) Global Health Expenditure data Organisation for Economic Co-operation and Development (OECD) Peterson-KFF Health System Tracker THE ANSWER Yes, the U.S. has the most expensive health care system in the world. WHAT WE FOUND A country’s health care costs are typically measured by adding up all health care spending for people, governments, organizations and businesses, and dividing that by the total number of people in the country. The figure includes spending on personal health care, such as drugs and hospital visits, as well as collective care, such as public health services and health administration. The U.S. health care system is more expensive per person than any other country’s health care system, both in raw dollar amounts and when spending is adjusted to account for the cost of living in each country. This finding is consistent across data from multiple international organizations. In 2021, the most recent year for which the World Health Organization (WHO) Global Health Expenditure database published numbers for all countries, the U.S. spent just over $12,000 on health care per person. The only other country that spent more than $10,000 was Switzerland, which spent nearly $10,900 per person. However, when adjusted for the cost of goods in each country, the spending gap is even larger. Switzerland, which still spent the second most, spent about $9,000 on health care per person in 2021. The U.S., on the other hand, spent about $12,000 per person. Looking at another dataset, in 2022, the U.S. spent nearly $12,600 on health care per person, according to the Organisation for Economic Co-operation and Development (OECD) , an international organization made up of about 40 wealthy member countries. The OECD collects data on its member countries. The OECD country that spent the next most on health care per person, when adjusted for the cost of goods in that country, was still Switzerland. It spent just over $8,000 per person, according to the OECD’s data. Wealthy countries do tend to spend more money on health care per person than lower income countries, according to the Peterson-KFF Health System Tracker , a partnership between two public health non-profit organizations. But Denmark, Switzerland, Ireland, Luxembourg and Norway are all wealthier per person than the U.S. is and spend significantly less on health care per person, according to the Health System Tracker. Ireland spends less than half of what the U.S. does on health care per person. Life expectancy and health outcomes When it comes to how the U.S. ranks for life expectancy and health outcomes, it’s true that the U.S. is behind dozens of other countries, although several international organizations don’t place the U.S. exactly at number 42. A CIA World Factbook estimate for 2024 ranked the U.S. 35th in life expectancy once territories are excluded. The WHO ranked the U.S. 45th in the world, excluding territories, in life expectancy in 2021, the most recent year for which the WHO has data for all countries. WHO data from 2019 shows that the U.S. was 40th in life expectancy prior to the pandemic. The U.S. experienced a bigger drop in life expectancy than other similarly wealthy countries during the COVID-19 pandemic, according to the Health System Tracker , which is run by the nonprofits The Peterson Center on Healthcare and KFF. The Health System Tracker explains this is because the pandemic increased mortality and premature death rates in the U.S. by more than it did in most peer countries, making the U.S. fall further behind in life expectancy. Related Articles Yes, it’s safe to use Login.gov to access Social Security accounts online VERIFYING claims related to Luigi Mangione after his arrest in the UnitedHealthcare CEO killing Why we can’t VERIFY a chart showing UnitedHealthcare denies more claims than other insurers The VERIFY team works to separate fact from fiction so that you can understand what is true and false. Please consider subscribing to our daily newsletter , text alerts and our YouTube channel . You can also follow us on Snapchat , Instagram , Facebook and TikTok . Learn More » Follow Us YouTube Snapchat Instagram Facebook TikTok Want something VERIFIED? Text: 202-410-8808
New AI winners beyond Big Tech are set to emerge, UK fund manager predicts